Currently available antitussives

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 2, 2009, Pages 148-151

  Dicpinigaitis, Peter V ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antihistamine; Antitussive; Baclofen; Benzonatate; Codeine; Common cold; Cough; Dextromethorphan; Guaifenesin; Levodropropizine; Theobromine

Indexed keywords

AMITRIPTYLINE; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BACLOFEN; BENZONATATE; CODEINE; DEXBROMPHENIRAMINE; DEXTROMETHORPHAN; DIHYDROCODEINE; DIPHENHYDRAMINE; GUAIFENESIN; HYDROCODONE; LEVDROPROPIZINE; MOGUISTEINE; MORPHINE; NON PRESCRIPTION DRUG; OPIATE; THEOBROMINE; TIOTROPIUM BROMIDE;

ARTICLE; CLINICAL TRIAL; COUGHING; DRUG ABUSE; DRUG CHOICE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; GASTROINTESTINAL IRRITATION; HUMAN; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SLOW RELEASE FORMULATION; TREATMENT OUTCOME; VIRAL UPPER RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ANALGESICS, OPIOID; ANTITUSSIVE AGENTS; BRONCHODILATOR AGENTS; CHRONIC DISEASE; COUGH; EXPECTORANTS; HISTAMINE ANTAGONISTS; HUMANS; NARCOTICS; PARASYMPATHOLYTICS; RESPIRATORY TRACT INFECTIONS;

EID: 61649093983     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.08.002     Document Type: Article

References (52)

1. Burt C.W., and Schappert S.M. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999-2000. Vital Health Stat 13 157 (2004) 1-70
2. Schroeder K., and Fahey T. Systematic review of randomised controlled trials of over-the-counter medicines for acute cough in adults. Br Med J 324 (2002) 329-331
3. Bolser D.C. Cough suppressant and pharmacologic protussive therapy. In: Diagnosis and management of cough: ACCP evidence-based clinical practice guidelines. Chest 129 (2006) 238S-249S
4. Pratter M.R. Overview of common causes of chronic cough. In: Diagnosis and management of cough. ACCP evidence-based clinical practice guidelines. Chest 129 (2006) 59S-62S
5. Chung K.F. Currently available cough suppressants for chronic cough. Lung 186 Suppl. 1 (2008) S82-S87
6. Sevelius H., and Colmore J.P. Objective assessment of antitussive agents in patients with chronic cough. J New Drugs 6 (1966) 216-223
7. Sevelius H., McCoy J.F., and Colmore J.P. Dose response to codeine in patients with chronic cough. Clin Pharmacol Ther 12 (1971) 449-455
8. Aylward M., Maddock J., Davies D.E., Protheroe D.A., and Leideman T. Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects. Eur J Resp Dis 65 (1984) 283-291
9. Eccles R., Morris S., and Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther 17 (1992) 175-180
10. Freestone C., and Eccles R. Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol 49 (1997) 1045-1049
11. Smith J., Owen E., Earis J., and Woodcock A. Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol 117 (2006) 831-835
12. Morice A.H., Menon M.S., Mulrennan S.A., Everett C.F., Wright C., Jackson J., et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med 175 (2007) 312-315
13. Tukiainen H., Karttunen P., Silvasti M., Flygare U., Korhonen R., Korhonen T., et al. The treatment of acute transient cough: a placebo-controlled comparison of dextromethorphan and dextromethorphan-beta 2-sympathomimetic combination. Eur J Respir Dis 69 (1986) 95-99
14. Korppi M., Laurikainen K., Pietikainen M., and Silvasti M. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 80 (1991) 969-971
15. Parvez L., Vaidya M., Sakhardande A., Subburaj S., and Rajagopalan T.G. Evaluation of antitussive agents in man. Pulm Pharmacol 9 (1996) 299-308
16. Lee P.C.L., Jawad M.S., and Eccles R. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 52 (2000) 1137-1142
17. Pavesi L., Subburaj S., and Porter-Shaw K. Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis. Chest 120 (2001) 1121-1128
18. Curley F.J., Irwin R.S., Pratter M.R., Stivers D.H., Doern G.V., Vernaglia P.A., et al. Am Rev Respir Dis 138 (1988) 305-311
19. Lilienfeld L.S., Rose J.C., and Princiotto J.V. Antitussive activity of diphenhydramine in chronic cough. Clin Pharmacol Ther 19 (1976) 421-425
20. Pratter M.R., Bartter T., Akers S., and Dubois J. An algorithmic approach to chronic cough. Ann Intern Med 119 (1993) 977-983
21. Bolser D.C. Older-generation antihistamines and cough due to upper airway cough syndrome (UACS): efficacy and mechanism. Lung 186 Suppl. 1 (2008) S74-S77
22. Banner A.S. Pharmacologic treatment of cough. In: Leff A.R. (Ed). Pulmonary and critical care pharmacology and therapeutics (2002), McGraw-Hill, New York 673-679
23. Ziment I. Agents that affect mucus and cough. In: Witek T.J., and Schacter E.N. (Eds). Pharmacology and therapeutics in respiratory care (1994), WB Saunders, Philadelphia 239-257
24. Doona M., and Walsh D. Benzonatate for opioid-resistant cough in advanced cancer. Palliat Med 12 (1997) 55-58
25. Lavezzo A., Mellilo G., Clavenna G., and Omini C. Peripheral site of action of levodropropizine in experimentally-induced cough: role of sensory neuropeptides. Pulm Pharmacol 5 (1992) 143-147
26. Fumagalli G., Cordaro C.I., Vanasia M., Balzarotti C., Camusso L., Caiazzo G., et al. A comparative study of the antitussive activity of levodropropizine and dropropizine in the citric acid-induced cough model in normal subjects. Drugs Exp Clin Res 18 (1992) 303-309
27. Bariffi F., Tranfa C., Vatrella A., and Ponticiello A. Protective effect of levodropropizine against cough induced by inhalation of nebulized distilled water in patients with obstructive lung disease. Drugs Exp Clin Res 18 (1992) 113-118
28. Allegra L., and Bossi R. Clinical trials with the new antitussive levodropropizine in adult bronchitic patients. Arzneimittel-Forschung 38 (1988) 1163-1166
29. Catena E., and Daffonchio L. Efficacy and tolerability of levodropropizine in adult patients with nonproductive cough. Comparison with dextromethorphan. Pulm Pharmacol 10 (1997) 89-96
30. Luporini G., Barni S., Marchi E., and Daffonchio L. Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. Eur Respir J 12 (1998) 97-101
31. Gallico L., Borghi A., Dalla Rossa C., Ceserani R., and Tognella S. Moguisteine: a novel peripheral non-narcotic antitussive drug. Br J Pharmacol 112 (1994) 795-800
32. Morita K., and Kamei J. Involvement of ATP-sensitive K(+) channels in the anti-tussive effect of moguisteine. Eur J Pharmacol 395 (2000) 161-164
33. Aversa C., Cazzola M., Clini V., Dal Negro R., Maiorano V., Tana F., et al. Clinical trial of the efficacy and safety of moguisteine in patients with cough associated with chronic respiratory diseases. Drugs Exp Clin Res 19 (1993) 273-279
34. Barnabe R., Berni F., Clini V., Pirrelli M., Pisani Ceretti A., Robuschi M., et al. The efficacy and safety of moguisteine in comparison with codeien phosphate in patients with chronic cough. Monaldi Arch Chest Dis 50 (1995) 93-97
35. United States Dept. of Health and Human Services. Expectorant drug products for over-the-counter human use: final monograph (1989), Federal Register 54, Washington, DC p. 8494-509
36. Ayres P.J.W. Experimental and clinical methodologies in efficacy of expectorants using the example of guaifenesin. In: Loew D., and Rietbrock N. (Eds). Phytopharmaka III (1997), Steinkopff Verlag, Darmstadt, Germany 151-160
37. Robinson R.E., Cummings W.B., and Deffenbaugh E.R. Effectiveness of guaifenesin as an expectorant: a cooperative double-blind study. Curr Ther Res 22 (1977) 284-296
38. Kuhn J.J., Hendley O., Adams K.F., Clark J.W., and Gwaltney J.M. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest 82 (1982) 713-718
39. Cohen B.M. Antitussive effect of guaifenesin (letter). Chest 84 (1983) 118-119
40. Dicpinigaitis P.V., and Gayle Y.E. Effect of guaifenesin on cough reflex sensitivity. Chest 124 (2003) 2178-2181
41. Jeyakumar A., Brickman T.M., and Haben M. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 116 (2006) 2108-2112
42. Bastian R.W., Vaidya A.M., and Delsupehe K.G. Sensory neuropathic cough: a common and treatable cause of chronic cough. Otolaryngol Head Neck Surg 135 (2006) 17-21
43. Bolser D.C., Aziz S.M., DeGennaro F.C., Kreutner W., Egan R.W., Siegel M.I., et al. Antitussive effects of GABA-B agonists in the cat and guinea-pig. Br J Pharmacol 110 (1993) 491-495
44. Dicpinigaitis P.V., and Dobkin J.B. Antitussive effect of the GABA-agonist baclofen. Chest 111 (1997) 996-999
45. Dicpinigaitis P.V., Dobkin J.B., Rauf K., and Aldrich T.K. Inhibition of capsaicin-induced cough by the γ-aminobutyric acid agonist baclofen. J Clin Pharmacol 38 (1998) 364-367
46. Dicpinigaitis P.V., Grimm D.R., and Lesser M. Baclofen-induced cough suppression in cervical spinal cord injury. Arch Phys Med Rehabil 81 (2000) 921-923
47. Dicpinigaitis P.V., and Rauf K. Treatment of chronic, refractory cough with baclofen. Respiration 65 (1998) 86-88
48. Dicpinigaitis P.V., Spinner L.M., and Santhyadka G.S. Effect of tiotropium on cough reflex sensitivity in acute viral cough (abstract). Eur Respir J 30 (2007) 544S
49. Usmani O.S., Belvisi M.G., Patel H.J., Crispino N., Birrell M.A., Korbonits M., et al. Theobromine inhibits sensory nerve activation and cough. FASEB J 19 (2005) 231-233
50. Dicpinigaitis P.V. Potential new cough therapies. Pulm Pharmacol Ther 17 (2004) 459-462
51. McLeod R.L., Correll C.C., Jia Y., and Anthes J.C. TRPV1 antagonists as potential antitussive agents. Lung 186 Suppl. 1 (2008) S59-S65
52. Belvisi M.G. Preclinical assessment of novel therapeutics on the cough reflex: cannabinoid agonists as potential antitussives. Lung 186 Suppl. 1 (2008) S66-S69